Generate Biomedicines

Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
Biotech Financing, IPO Tide May Be Turning – Signs of a Potential Recovery?
BioSpace
biotech
IPOs
Neumora Therapeutics
Rome Therapeutics
Generate Biomedicines
Flag link:
Generate raises $273M—$100M less than previous round—but a huge bounty
Generate raises $273M—$100M less than previous round—but a huge bounty
Fierce Biotech
Generate Biomedicines
funding
Flagship Pioneering
Flag link:
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs
Fierce Biotech
Amgen
Generate Biomedicines
biobucks
drug development
drug discovery
artificial intelligence
Flag link:
Flagship's machine learning startup Generate bags $370M in latest round with plans for a big hiring spree
Flagship's machine learning startup Generate bags $370M in latest round with plans for a big hiring spree
Endpoints
Generate Biomedicines
funding
Flagship Pioneering
startups
machine learning
artificial intelligence
Flag link:
Former Merck Exec Joins Flagship to Helm AI Startup Generate Biomedicines
Former Merck Exec Joins Flagship to Helm AI Startup Generate Biomedicines
BioSpace
Merck
Generate Biomedicines
Flag link:
Flagship reveals machine learning-based protein drug discovery startup Generate Biomedicines
Flagship reveals machine learning-based protein drug discovery startup Generate Biomedicines
MedCity News
Flagship Pioneering
COVID-19
startups
Generate Biomedicines
Flag link: